HuagongsheHuagongshe Chemistry Print Report · For research reference only
2-(4-(azidomethyl)-1H-imidazol-1-yl)-5-bromopyridine → (1-(5-bromopyridin-2-yl)-1H-imidazol-4-yl)methanamine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 2-(4-(azidomethyl)-1H-imidazol-1-yl)-5-bromopyridine | HCID 86614006 | — |
| Catalyst | Iron | HCID 23925 | — |
| Solvent | Acetic Acid | HCID 176 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | (1-(5-bromopyridin-2-yl)-1H-imidazol-4-yl)methanamine | HCID 68502878 | 55.8% |
Reaction Steps
A mixture of 2-(4-(azidomethyl)-1H-imidazol-1-yl)-5-bromopyridine (500 mg, 1.79 mmol) and iron powder (767 mg, 13.7 mmol) in EtOH (8 mL) and HOAc (6 mL) was heated at reflux for 2 h. It was filtered through celite. The filtrate was concentrated in vacuo. The residue was partitioned between 5% NaHCO3 and EtOAc. The biphasic solution was filtered. The EtOAc phase was separated, dried over Na2SO4, and concentrated in vacuo to give (1-(5-bromopyridin-2-yl)-1H-imidazol-4-yl)methanamine (253 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07696352B2 |
| Source dataset | uspto-grants-2010_04 |
| ORD ID | ord-55b44155e890468e94800070c96ed5ae |
| Source note | uspto-grants-2010_04 |